2010 Scrip 100 - Bursting the obesity bubble
This article was originally published in Scrip
Executive Summary
Disappointing on-market performance and safety concerns surrounding approved products have put paid to overly optimistic expectations of the growing obesity market. All the more worrying that current pipeline candidates follow such well worn paths, argues Jonathan Angell.